Company profile

Company profileOfficial Gazette noticesNo confirmed enforcement recordJapanese original

大同薬品工業株式会社

大同薬品工業株式会社· Corporate Number: 5150001014599

This page aggregates company identity, Official Gazette notices, enforcement records, related-company signals, and source-review links into one public-record profile.

Current page: Company profile

This page brings together Official Gazette notices, enforcement records, registry data, related-company signals, and source-review links for one company. Open individual enforcement records from the history section below.

Related tool Kiroku

Monitor website changes for 大同薬品工業株式会社

Open Kiroku monitoring and enter the official website, terms, IR, pricing, or announcement URL you want to track.

Open website monitoring
For developers: JSON integration details

You do not need this for normal browsing. Use it when integrating this company record into an internal tool or AI workflow.

/api/v1/search?q=5150001014599&limit=5

Public Record Summary

Total enforcement
0records
Official Gazette
2notices
Actions in last 3 years
0records
Actions in last year
0records
Latest public record
21 Apr 2026
Total penalties
-
Registry changes
0items

Company Identity and Registry Data

English display name
大同薬品工業株式会社
Original Japanese name
大同薬品工業株式会社
Kana name
だいどうやくひんこうぎょう
Corporate Number
5150001014599
Registered address
奈良県葛城市新村214番地1
Employees
271

Note: Detailed gBizINFO registry data may not be available for this company yet. Use the public registry links below to review supplemental source information.

gBizINFO: fetched 21 May 2026

Corporate Number site: fetched 21 May 2026

Data sources

Official Gazette

Japanese Official Gazette company notices

2 notice(s)

Official Gazette company notice

Official Gazette noticeCompany noticeTranslation pending
Publication / issue / page
21 Apr 2026 Extra Edition 第93号 p.57
English summary
Company notice
Published company name
大同薬品工業株式会社
Published address
奈良県葛城市新村214番地1
Source
Official Gazette
Show original Japanese extracted fields
Original notice type
決算公告
Original related text
第 70 期決算公告 / 貸借対照表の要旨 (令和8年1月20日現在)
Original excerpt
第 70 期決算公告 / 貸借対照表の要旨 (令和8年1月20日現在)
Show official Japanese notice text

号外第 93 号 令和8年4月21日火曜日 官 報 (号  外) 公  告 会社その他の公告page="0057"page="0057"第 70 期決算公告    令和8年4月21日奈良県葛城市新村214番地1大同薬品工業株式会社代表取締役 宮地  誠page="0057"貸借対照表の要旨    (令和8年1月20日現在)科    目金 額(千円)資産の部流動資産5,318,084固定資産11,140,446  合計  16,458,530 負債及び   純資産の部 流動負債4,192,785固定負債639,027株主資本11,531,817資本金100,002利益剰余金11,431,815利益準備金13,750その他利益剰余金11,418,064(うち当期純利益)(584,299)評価・換算差額等94,899  合計  16,458,530©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.

Official Gazette company notice

Official Gazette noticeCompany noticeTranslation pending
Publication / issue / page
21 Apr 2025 Extra Edition 第89号 p.69
English summary
Company notice
Published company name
大同薬品工業株式会社
Published address
7年4月21日月曜日 官 報 (号 外) 公 告 会社その他の公告 第69期決算公告 令和7年4月 21 日奈良県葛城市新村214番地1
Source
Official Gazette
Show original Japanese extracted fields
Original notice type
決算公告
Original related text
第69期決算公告 / 貸借対照表の要旨 (令和7年1月20日現在)
Original excerpt
第69期決算公告 / 貸借対照表の要旨 (令和7年1月20日現在)
Show official Japanese notice text

号外第 89 号 令和7年4月21日月曜日 官 報 (号  外) 公  告 会社その他の公告page="0069"page="0069"  第69期決算公告  令和7年4月 21 日奈良県葛城市新村214番地1大同薬品工業株式会社代表取締役 宮地  誠page="0069"貸借対照表の要旨    (令和7年1月20日現在)科    目金 額(千円)資産の部流動資産5,656,190固定資産10,623,650  合計  16,279,841 負債及び   純資産の部 流動負債4,248,599固定負債655,237株主資本11,275,946資本金100,002利益剰余金11,175,943利益準備金13,750その他利益剰余金11,162,193(うち当期純利益)(1,770,825)評価・換算差額等100,058  合計  16,279,841©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.

Enforcement and administrative action history

No enforcement records are currently listed in RegBase's monitored sources.

RegBase automatically collects public disclosures from Japanese government sources. Non-public administrative guidance, oral warnings, and unpublished actions are not included. See data sources.

About this English name

No official English name source is recorded. The original Japanese name is shown.

If this profile contains an error or your company needs to add context, please use the correction request form. Submissions are reviewed under RegBase editorial policy.

This page mechanically aggregates and structures public government disclosures and public registry data under the editorial policy. It is not legal advice, credit scoring, or a final procurement decision. Always verify against the official source pages.